Home> Products> flexible dosing opipramol dihydrochloride

{ "products": [ { "_id": "6954d5cbb4697f18294b1c0e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Dydrogesterone 10 mg", "description": "DABROSTON 10 is a pharmaceutical preparation containing Dydrogesterone 10 mg, a synthetic progestogen that closely mimics the natural hormone progesterone produced by the female body. Manufactured with precision and care, DABROSTON 10 represents a breakthrough in women's reproductive health management, offering a reliable and effective solution for various gynecological conditions related to progesterone deficiency.\nUnlike many other synthetic progestogens, Dydrogesterone in DABROSTON 10 has a unique molecular structure that allows it to work specifically on the uterine lining without causing unwanted androgenic or estrogenic effects. This makes it an ideal choice for women requiring hormonal support while minimizing the risk of side effects commonly associated with other progestational agents.\nDABROSTON 10 is prescribed by healthcare professionals worldwide for conditions ranging from menstrual irregularities to fertility support, endometriosis management, and prevention of miscarriage in women with a history of recurrent pregnancy loss. Its versatility and safety profile have made it a cornerstone in modern gynecological therapeutics.\nUnderstanding Dydrogesterone and Its Uses\nDydrogesterone is an orally active progestogen that was specifically developed to provide the benefits of natural progesterone without the drawbacks of traditional synthetic progestogens. When you take DABROSTON 10, the Dydrogesterone is absorbed into your bloodstream and acts on progesterone receptors throughout your body, particularly in the uterus, where it exerts its primary therapeutic effects.\nPrimary Uses of DABROSTON 10:\nMenstrual Disorders: DABROSTON 10 is highly effective in treating various menstrual irregularities, including dysmenorrhea (painful periods), irregular menstrual cycles, and secondary amenorrhea (absence of periods). By regulating the endometrial lining, it helps restore normal menstrual patterns and reduces associated discomfort.\nEndometriosis Management: For women suffering from endometriosis, a condition where tissue similar to the uterine lining grows outside the uterus, causing pain and fertility issues, DABROSTON 10 helps suppress the growth of endometrial tissue and provides significant symptom relief.\nLuteal Phase Support: During fertility treatments or for women with luteal phase defects, DABROSTON 10 provides crucial progesterone support to help prepare the uterine lining for embryo implantation and maintain early pregnancy.\nPrevention of Miscarriage: Women with a history of recurrent miscarriage due to progesterone deficiency can benefit from DABROSTON 10, which helps maintain the uterine environment necessary for pregnancy continuation.\nPremenstrual Syndrome (PMS): The hormonal imbalances that contribute to PMS symptoms can be effectively managed with DABROSTON 10, providing relief from mood swings, breast tenderness, and bloating.\nHormone Replacement Therapy (HRT): When combined with estrogen therapy in postmenopausal women, DABROSTON 10 protects the uterine lining from excessive growth (endometrial hyperplasia) that estrogen alone might cause.\nDysfunctional Uterine Bleeding: Abnormal uterine bleeding not caused by organic pathology can be controlled with DABROSTON 10 by regulating the endometrial cycle.\nKey Benefits of DABROSTON 10\n1. Natural Hormone Profile\nOne of the most significant advantages of DABROSTON 10 is its molecular similarity to natural progesterone. This means your body recognizes and processes it almost identically to the progesterone it produces naturally, resulting in better tolerance and effectiveness.\n2. Minimal Side Effects\nUnlike many synthetic progestogens that can cause masculinizing effects, weight gain, or mood disturbances, DABROSTON 10 has a remarkably clean side effect profile. It doesn't possess androgenic, estrogenic, or glucocorticoid activity, which means fewer unwanted effects on your body.\n3. Selective Progestational Activity\nDABROSTON 10 works specifically on the uterine lining where it's needed most, without significantly affecting other body systems. This targeted action makes it highly effective for gynecological conditions while maintaining safety.\n4. Oral Administration\nThe convenience of oral dosing makes DABROSTON 10 easy to incorporate into your daily routine. No injections or invasive procedures are required, and the tablets can be taken with or without food.\n5. Pregnancy Safe\nWhen prescribed appropriately, DABROSTON 10 is considered safe during pregnancy, particularly in the first trimester for women at risk of miscarriage. It doesn't harm fetal development and can be crucial in maintaining healthy pregnancies.\n6. Metabolic Neutrality\nDABROSTON 10 doesn't adversely affect lipid metabolism, glucose tolerance, or blood clotting factors in the way some other hormonal preparations might. This makes it suitable for a broader range of women, including those with metabolic concerns.\n7. Flexible Dosing\nThe 10 mg strength allows for flexible dosing regimens tailored to individual needs. Your healthcare provider can adjust the timing and duration of treatment based on your specific condition and response.\n8. Proven Efficacy\nDecades of clinical use and extensive research have established DABROSTON 10 (Dydrogesterone) as a gold standard in progestogen therapy. Its effectiveness has been demonstrated in numerous clinical trials and real-world applications.\n9. Quality of Life Improvement\nBy effectively managing hormonal imbalances and their associated symptoms, DABROSTON 10 significantly improves quality of life. Women report better sleep, improved mood, reduced pain, and enhanced overall well-being.\n10. Supports Fertility Goals\nFor women trying to conceive, DABROSTON 10 provides essential hormonal support that can make the difference between conception success and failure, particularly in cases of luteal phase deficiency or recurrent pregnancy loss.\nUnderstanding Side Effects\nWhile DABROSTON 10 is generally well-tolerated, like all medications, it may cause side effects in some individuals. Understanding these potential effects helps you make informed decisions and know when to contact your healthcare provider.\nCommon and Generally Mild Side Effects:\nHeadache: Some women experience mild to moderate headaches, particularly when first starting treatment. These typically resolve as your body adjusts to the medication.\nNausea: Mild nausea may occur, especially if taken on an empty stomach. Taking DABROSTON 10 with food can help minimize this effect.\nBreast Tenderness: Temporary breast sensitivity or tenderness is relatively common and usually subsides with continued use.\nMood Changes: Mild mood fluctuations may occur, though DABROSTON 10 is less likely to cause mood disturbances compared to other progestogens.\nDizziness: Some women report feeling slightly dizzy, particularly shortly after taking the medication.\nAbdominal Discomfort: Mild stomach discomfort or bloating may occur but is generally temporary.\nLess Common Side Effects:\nBreakthrough bleeding or spotting between periods may occur, especially during the first few cycles of treatment. Fatigue or drowsiness can affect some individuals. Skin reactions such as mild rash or itching are possible but rare. Some women may experience changes in menstrual flow pattern. Rarely, liver function changes may occur, which is why periodic monitoring may be recommended for long-term use.\nWhen to Contact Your Healthcare Provider:\nWhile serious side effects are rare with DABROSTON 10, you should contact your doctor immediately if you experience severe abdominal pain, significant mood changes or depression, jaundice (yellowing of skin or eyes), severe allergic reactions including difficulty breathing or swelling, severe or persistent headaches, visual disturbances, or unusual vaginal bleeding.\nIt's important to remember that most women taking DABROSTON 10 experience few to no side effects. The benefits of treatment typically far outweigh the potential risks, especially when the medication is used as prescribed under medical supervision.\nImportant Considerations\nNot for Everyone: DABROSTON 10 should not be used by women with known hypersensitivity to Dydrogesterone, undiagnosed vaginal bleeding, or certain liver conditions. Always inform your healthcare provider about your complete medical history.\nDrug Interactions: Certain medications may interact with DABROSTON 10, including some enzyme-inducing drugs that can reduce its effectiveness. Inform your doctor about all medications, supplements, and herbal products you're taking.\nPregnancy and Breastfeeding: While DABROSTON 10 is used to support early pregnancy, its use in later pregnancy stages should only be under medical supervision. Small amounts may pass into breast milk, so discuss with your doctor if you're breastfeeding.\nMonitoring: Depending on your condition and duration of treatment, your healthcare provider may recommend periodic check-ups and possibly liver function tests to ensure safe, continued use.\nHow to Use DABROSTON 10\nAlways take DABROSTON 10 exactly as prescribed by your healthcare provider. The dosing regimen varies depending on the condition being treated. It may be taken continuously, cyclically (certain days of your menstrual cycle), or in specific patterns for fertility support. Tablets should be swallowed whole with water and can be taken with or without food. If you miss a dose, take it as soon as you remember unless it's nearly time for your next dose. Never double up doses to make up for a missed one.\nConclusion\nDABROSTON 10 represents a significant advancement in women's reproductive health management, offering a safe, effective, and well-tolerated solution for various gynecological conditions related to progesterone deficiency. Its unique molecular structure, which closely mimics natural progesterone, sets it apart from other synthetic progestogens by providing therapeutic benefits without the unwanted androgenic effects commonly associated with hormonal treatments.", "price": 637.0, "discountamount": 191.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2258, "imageuri": "https://productimages.withfloats.com/actual/6954d5cd5542d9b6b39275fa.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6954d5cd5542d9b6b39275fa.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-12-31T07:50:35.025Z", "updatedon": "2026-01-15T06:32:25.314Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/dydrogesterone-10-mg/2258", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "DABROSTON 10", "category": "GYANECOLOGYRANGE", "tags": [ "Dydrogesterone 10 mg", "Menstrual Disorders.", "Prevention of Miscarriage.", "Premenstrual Syndrome (PMS).", "endometrial tissue proliferation outside the uterus.", "Endometriosis Management.", "hormonal treatments.", "dydrogesterone 10 mg.", "dydrogesterone 10 mg tablet uses.", "dydrogesterone 10 mg tablet uses in hindi", "dydrogesterone 10 mg tablet uses in pregnancy.", "tablet dydrogesterone 10 mg.", "dydrogesterone 10 mg in pregnancy.", "dydrogesterone 10 mg tablet price." ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "66d999cc236afd258ed10348", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Nintedanib 100 mg", "description": "NINTEDONE 100 \nNintedanib 100 mg is a cutting-edge oral medication designed to combat progressive lung conditions and certain cancers, offering hope to patients facing debilitating fibrotic diseases. As a small-molecule tyrosine kinase inhibitor, it targets key pathways involved in abnormal cell growth and tissue scarring, making it a vital therapy for idiopathic pulmonary fibrosis (IPF), systemic sclerosis-associated interstitial lung disease (SSc-ILD), and progressive fibrosing interstitial lung diseases (PF-ILD). Manufactured to high standards, this formulation delivers precise dosing in a convenient capsule form, ensuring consistent absorption and efficacy for long-term management.​\n\nUses of Nintedanib 100 mg\nNintedanib 100 mg stands out for its approved indications in slowing the decline of lung function in adults with IPF, a chronic and fatal lung disease characterized by progressive scarring of lung tissue. It is also indicated for SSc-ILD, where it helps manage lung fibrosis associated with systemic sclerosis, and PF-ILD, covering other chronic fibrosing lung conditions with a progressive phenotype. Beyond pulmonary fibrosis, Nintedanib has shown utility in oncology, particularly when combined with docetaxel for second-line treatment of advanced non-small cell lung cancer (NSCLC) of adenocarcinoma tumor histology, inhibiting tumor angiogenesis and growth.​\n\nThis medication addresses the underlying fibrotic processes by restricting fibroblast proliferation and migration, which are central to lung tissue damage. In clinical practice, physicians prescribe Nintedanib 100 mg for patients with confirmed diagnoses via high-resolution CT scans or lung biopsies, often after other treatments fail. Its versatility extends to off-label considerations in other cancers like pancreatic or colorectal, though primary use remains in respiratory fibrosis and lung cancer, providing a targeted approach where traditional therapies fall short.​\n\nKey Benefits of Nintedanib 100 mg\nOne of the primary benefits of Nintedanib 100 mg is its proven ability to reduce the rate of forced vital capacity (FVC) decline, a key measure of lung function, by up to 50% in IPF patients compared to placebo in landmark trials. This translates to slower disease progression, fewer acute exacerbations, and improved quality of life, allowing patients to maintain daily activities longer. The oral administration enhances patient compliance, avoiding the need for infusions or hospital visits.​\n\nSlows Fibrosis Progression: By inhibiting multiple tyrosine kinases, it curbs excessive scar tissue formation in the lungs, preserving respiratory capacity over time.​\n\nAnti-Angiogenic Effects: In cancer settings, it blocks vascular endothelial growth factor receptors (VEGFR), reducing tumor blood supply and metastasis risk.​\n\nBroad-Spectrum Kinase Inhibition: Targets fibroblast growth factor receptors (FGFR), platelet-derived growth factor receptors (PDGFR), and others, addressing multifaceted disease pathways.​\n\nManageable Long-Term Use: Clinical data supports sustained benefits with dose adjustments, minimizing hospitalizations for respiratory failure.​\n\nImproved Survival Metrics: In combination therapies for NSCLC, it extends progression-free survival, offering valuable time for patients.​\n\nThese advantages make Nintedanib 100 mg a cornerstone in modern pulmonology and oncology, backed by phase III trials demonstrating statistically significant outcomes in diverse patient populations.​\n\nSide Effects of Nintedanib 100 mg\nWhile effective, Nintedanib 100 mg can cause gastrointestinal side effects as the most common issue, affecting over 60% of users primarily due to its impact on kinase signaling in the gut. Diarrhea often starts within the first two weeks and is typically manageable with dose reduction or antidiarrheal agents like loperamide. Other frequent effects include nausea, vomiting, and decreased appetite, which may lead to weight loss if not addressed.​\n\nMore serious side effects warrant close monitoring:\n\nLiver Enzyme Elevations: Hepatotoxicity occurs in about 10-15% of patients, necessitating monthly liver function tests, especially in those with pre-existing liver conditions.​\n\nCardiovascular Risks: Potential for arterial thromboembolism or hypertension; baseline cardiac evaluation is recommended.​\n\nBleeding Events: Due to VEGF inhibition, minor bleeding like epistaxis is common, but gastrointestinal hemorrhage requires immediate attention.​\n\nRare but Severe: Interstitial lung disease progression (paradoxical worsening), perforations, or severe infections in immunocompromised patients.​\n\nPatients should report persistent diarrhea, abdominal pain, jaundice, or unusual fatigue promptly. Contraindications include pregnancy (category D), active bleeding, or hypersensitivity, with strong recommendations against use in moderate to severe hepatic impairment.​\n\nDosage and Administration Insights\nTypically initiated at 150 mg twice daily for IPF and ILD, Nintedanib 100 mg allows for flexible dosing—starting lower at 100 mg BID if tolerated poorly, with food to reduce GI upset. For NSCLC, it's 200 mg BID with docetaxel cycles. Regular monitoring every 2-3 months adjusts for tolerance, emphasizing adherence to slow disease modification.​\n\nConclusion\nNintedanib 100 mg represents a breakthrough in managing progressive fibrotic lung diseases and select cancers, delivering targeted inhibition of fibrotic and angiogenic pathways for tangible clinical benefits. Its ability to slow FVC decline, enhance patient quality of life, and integrate into combination regimens underscores its value, despite manageable side effects like diarrhea that respond well to supportive care. For those battling IPF, SSc-ILD, or NSCLC, Nintedanib 100 mg offers a proactive defense against relentless progression, empowering longer, more active lives under specialist guidance.​", "price": 795.0, "discountamount": 296.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "one capsule", "weight loss", "scar tissue", "key players", "Key Benefits", "lung function", "initial stages", "abdominal pain", "fibrous tissue", "key ingredient", "Bleeding Events", "fibrotic tissue", "daily activities", "tyrosine kinases", "fibrotic process", "Nintedanib 100 mg", "multiple pathways", "active ingredient", "sudden worsenings", "crucial medication", "recommended dosage", "Decreased Appetite", "signaling pathways", "multiple receptors", "overall well-being", "disease progression", "acute exacerbations", "healthcare provider", "Common side effects", "elevated liver enzymes", "Gastrointestinal Issues", "other fibrotic diseases", "Liver Enzyme Elevations", "tyrosine kinase inhibitor", "progressive lung conditions", "other fibrotic lung diseases", "idiopathic pulmonary fibrosis", "potent pharmaceutical formulation", "fibroblast growth factor receptor", "platelet-derived growth factor receptor", "vascular endothelial growth factor receptor" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1971, "imageuri": "https://productimages.withfloats.com/actual/66d999d4f2036c2969cdeca8.png", "tileimageuri": "https://productimages.withfloats.com/tile/66d999d4f2036c2969cdeca8.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-09-05T11:45:16.665Z", "updatedon": "2026-01-27T08:43:22.823Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/nintedanib-100-mg/1971", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "NINTEDONE 100 ", "category": "NEPHROLOGYRANGE", "tags": [ "lung conditions and certain cancers", "Nintedanib 100 mg", "pulmonary fibrosis (IPF)", "fibrosis and lung cancer", "nintedanib 100 mg", "nintedanib capsules 100 mg", "nintedanib 100 mg capsules", "nintedanib 100 mg medicine", "nintedanib 100 mg tablet uses", "what is nintedanib 100 mg used for", "how nintedanib 100 mg works", "nintedanib 100 mg uses and benefits", "nintedanib 100 mg for lung disease", "nintedanib 100 mg for pulmonary fibrosis", "nintedanib 100 mg for idiopathic pulmonary fibrosis", "nintedanib 100 mg for interstitial lung disease", "nintedanib capsules for chronic lung disease", "nintedanib 100 mg price in india", "nintedanib 100 mg capsules price", "buy nintedanib 100 mg online", "nintedanib 100 mg supplier india", "nintedanib 100 mg manufacturer", "when should nintedanib 100 mg be taken", "who should take nintedanib 100 mg", "can nintedanib slow lung fibrosis", "how long to take nintedanib 100 mg", "does nintedanib cure pulmonary fibrosis" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666be6b8aa93342004eef58f", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 2 ", "description": "ROPINPRIME 2 \nRopinirole (2 mg)\nIntroduction:\nRopinprime 2 is a medication containing Ropinirole, a potent dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 2mg, Ropinprime 2 is designed to effectively alleviate symptoms by mimicking dopamine's action in the brain, thus improving motor function and enhancing the quality of life for patients.\nKey Features and Benefits:\nDopamine Agonist:\nRopinprime 2 acts as a dopamine agonist, stimulating dopamine receptors in the brain. This action helps reduce motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 2 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 2 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 2 mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage for Parkinson's Disease:\n\nThe recommended starting dose of Ropinprime 2 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability. Maintenance doses usually range from 1mg to 8mg per day, divided into multiple doses.\nInitial Dosage for Restless Legs Syndrome:\n\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. The dose may be increased to 0.5mg and then to 1 mg, depending on patient response and symptom control.\nAdministration Instructions:\n\nSwallow Ropinprime 2 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\n\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 2 therapy to ensure therapeutic efficacy and patient safety.\n\n\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \n", "price": 126.0, "discountamount": 38.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "RLS", "1mg", "8mg", "life", "aids", "food", "brain", "Order", "EMAIL", "0.5mg", "water", "0.25mg", "action", "nausea", "bedtime", "disease", "tremors", "patients", "Benefits", "condition", "Parkinson", "stiffness", "Ropinirole", "likelihood", "medication", "information", "Introduction", "bradykinesia", "independence", "tolerability", "initial dose", "sterisonline", "sterispharma", "greater ease", "Key Features", "CALL/WHATSAPP", "sleep quality", "starting dose", "motor symptoms", "patient safety", "multiple doses", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "patient response", "symptom severity", "daily activities", "clinical response", "Maintenance doses", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "2mg dosage strength", "Ropinprime 2 therapy", "healthcare providers", "therapeutic efficacy", "Continued Monitoring", "dopaminergic activity", "overall motor function", "potential side effects", "potent dopamine agonist", "Improved Motor Function", "uncomfortable sensations", "flexible dosing regimens", "individual patient needs", "Administration Instructions", "Swallow Ropinprime 2 tablets", "Restless Legs Syndrome Relief" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1895, "imageuri": "https://productimages.withfloats.com/actual/667d15dbce74849f89cdd68a.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d15dbce74849f89cdd68a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:44:08.261Z", "updatedon": "2025-12-12T07:47:28.099Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-2-/1895", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 2 ", "category": "NEUROLOGY RANGE", "tags": [ "Ropinirole (2mg)", "ROPINPRIME 2", "ropinirole side effects", "ropinirole side effects: weight gain", "ropinirole side effects in elderly" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666be4714cb45413344ec323", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "ROPINPRIME 0.5 ", "description": "ROPINPRIME 0.5 \nRopinirole (0.5mg)\nIntroduction:\n\nRopinprime 0.5 contains Ropinirole, a dopamine agonist used primarily for treating Parkinson's disease and restless legs syndrome (RLS). With a dosage strength of 0.5mg, Ropinprime 0.5 aims to alleviate symptoms by mimicking the action of dopamine in the brain, thus improving motor function and enhancing quality of life for patients.\nKey Features and Benefits:\n\nDopamine Agonist:\n\nRopinprime 0.5 acts as a dopamine agonist, directly stimulating dopamine receptors in the brain. This action helps reduce the motor symptoms associated with Parkinson's disease, such as tremors, stiffness, and bradykinesia (slowed movement).\nImproved Motor Function:\n\nBy enhancing dopaminergic activity, Ropinprime 0.5 aids in improving overall motor function, allowing patients to perform daily activities with greater ease and independence.\nRestless Legs Syndrome Relief:\n\nRopinprime 0.5 is also effective in managing the symptoms of restless legs syndrome (RLS), a condition characterized by an uncontrollable urge to move the legs, often accompanied by uncomfortable sensations. Ropinirole helps reduce these symptoms, improving sleep quality and overall comfort.\nFlexible Dosing:\n\nThe 0.5mg dosage strength allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, symptom severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Ropinprime 0.5 for Parkinson's disease is typically 0.25mg taken three times daily. The dose can be gradually increased based on clinical response and tolerability.\nRestless Legs Syndrome:\nFor RLS, the initial dose is usually 0.25mg taken once daily, 1 to 3 hours before bedtime. Dosage may be adjusted according to patient response and symptom control.\nAdministration Instructions:\nSwallow Ropinprime 0.5 tablets whole with water, with or without food. Taking the medication with food may help reduce the likelihood of nausea.\nContinued Monitoring:\nRegular monitoring of symptoms, motor function, and potential side effects is essential during Ropinprime 0.5 therapy to ensure therapeutic efficacy and patient safety.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/ropinprime-0-5-133627", "price": 56.0, "discountamount": 16.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "RLS", "aids", "life", "food", "Order", "water", "brain", "EMAIL", "0.25mg", "nausea", "action", "bedtime", "disease", "tremors", "patients", "Benefits", "stiffness", "condition", "Parkinson", "Ropinirole", "likelihood", "medication", "information", "Introduction", "initial dose", "independence", "greater ease", "tolerability", "Key Features", "sterispharma", "bradykinesia", "sterisonline", "CALL/WHATSAPP", "sleep quality", "starting dose", "patient safety", "motor symptoms", "Initial Dosage", "overall comfort", "treatment plans", "slowed movement", "symptom control", "dopamine agonist", "patient response", "daily activities", "symptom severity", "clinical response", "Regular monitoring", "dopamine receptors", "uncontrollable urge", "Continued Monitoring", "healthcare providers", "therapeutic efficacy", "0.5mg dosage strength", "dopaminergic activity", "Ropinprime 0.5 therapy", "overall motor function", "potential side effects", "Improved Motor Function", "individual patient needs", "uncomfortable sensations", "flexible dosing regimens", "Administration Instructions", "Restless Legs Syndrome Relief", "Swallow Ropinprime 0.5 tablets" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1893, "imageuri": "https://productimages.withfloats.com/actual/666be475844f2600246a0b63.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666be475844f2600246a0b63.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-14T06:34:25.708Z", "updatedon": "2025-12-12T07:56:21.102Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/ropinprime-0-5-/1893", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ROPINPRIME 0.5 ", "category": "NEUROLOGY RANGE", "tags": [ "ropinprime 0.5 mg tablet 10", "ropinprime 0.5 mg tablet uses", "ropin 0.5 injection", "ropinirole warnings", "ropinirole side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666ae69aaebebd0900165264", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "RASAGAIL 1", "description": "RASAGAIL 1\nRasagail 1.0 \nIntroduction:\n\nRasagail 1.0 embodies the therapeutic efficacy of Rasagiline, a potent monoamine oxidase-B (MAO-B) inhibitor renowned for its role in managing Parkinson's disease. With a dosage strength of 1.0mg, Rasagail 1.0 offers a targeted approach to alleviate symptoms, enhance motor function, and potentially slow disease progression in Parkinson's patients.\nKey Features and Benefits:\n\nMAO-B Inhibition:\n\nRasagail 1.0 exerts its primary action by selectively inhibiting MAO-B enzymes, leading to increased dopamine levels within the brain's striatum. This mechanism aids in alleviating motor symptoms and improving overall motor function.\nNeuroprotection:\n\nBeyond symptom relief, Rasagail 1.0 demonstrates neuroprotective properties by reducing oxidative stress, preserving neuronal integrity, and potentially exerting disease-modifying effects in Parkinson's disease.\nImproved Motor Function:\n\nBy enhancing dopaminergic neurotransmission, Rasagail 1.0 contributes to smoother motor coordination, reduced rigidity, tremors, and bradykinesia, fostering greater mobility and functional independence.\nFlexible Dosing:\n\nRasagail 1.0 allows for flexible dosing regimens, enabling healthcare providers to tailor treatment plans based on individual patient needs, disease severity, and response to therapy.\nDosage and Administration:\n\nInitial Dosage:\nThe recommended starting dose of Rasagail 1.0 is 1.0mg once daily, administered orally with or without food. Dosage adjustments may be considered based on individual patient response and tolerability.\nTitration and Maintenance:\nTitration of Rasagail 1.0 may occur under medical supervision to achieve optimal therapeutic benefits while minimizing adverse effects. Maintenance doses are typically adjusted as needed to sustain symptom control.\nContinued Monitoring:\nOngoing clinical monitoring of Parkinson's disease symptoms, motor function, and potential side effects is essential during Rasagail 1.0 therapy to ensure treatment efficacy and patient safety.For further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/rasagail-1-0-133623\n", "price": 135.0, "discountamount": 40.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "role", "food", "brain", "1.0mg", "Order", "EMAIL", "tremors", "patients", "rigidity", "striatum", "Titration", "Parkinson", "mechanism", "Rasagiline", "information", "Introduction", "Key Features", "sterisonline", "sterispharma", "tolerability", "bradykinesia", "starting dose", "CALL/WHATSAPP", "MAO-B enzymes", "Initial Dosage", "Administration", "patient safety", "symptom relief", "motor symptoms", "primary action", "treatment plans", "adverse effects", "symptom control", "dosage strength", "Neuroprotection", "dopamine levels", "MAO-B Inhibition", "disease symptoms", "disease severity", "greater mobility", "oxidative stress", "MAO-B) inhibitor", "Maintenance doses", "targeted approach", "treatment efficacy", "neuronal integrity", "Dosage adjustments", "medical supervision", "disease progression", "healthcare providers", "Continued Monitoring", "therapeutic efficacy", "Rasagail 1.0 therapy", "potential side effects", "overall motor function", "functional independence", "Improved Motor Function", "individual patient needs", "flexible dosing regimens", "disease-modifying effects", "potent monoamine oxidase-B", "neuroprotective properties", "Ongoing clinical monitoring", "smoother motor coordination", "individual patient response", "optimal therapeutic benefits", "dopaminergic neurotransmission" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1888, "imageuri": "https://productimages.withfloats.com/actual/666ae69dc9162f54a1593ccc.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/666ae69dc9162f54a1593ccc.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T12:31:22.172Z", "updatedon": "2024-06-26T07:19:57.74Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/rasagail-1/1888", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "RASAGAIL 1", "category": "NEUROLOGY RANGE", "tags": [ "RASAGAIL 1", "rasagiline 1 mg price", "rasagiline 1 mg uses", "rasagiline benefits", "rasagiline side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666acc861542dd108c562398", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "OXCARBZEN 300 ", "description": "OXCARBZEN 300 \nOxcarbazepine IP (300mg)\nIntroduction:\n\nOXCARBZEN 300 contains Oxcarbazepine IP (300 mg), an antiepileptic medication used to manage and treat partial seizures in epilepsy. Oxcarbazepine works by stabilizing the electrical activity in the brain, preventing the excessive electrical discharges that cause seizures.\nKey Features and Benefits:\n\nSeizure Control: Oxcarbazepine effectively reduces the frequency and severity of partial seizures, improving the quality of life for individuals with epilepsy.\nMood Stabilization: Besides its antiepileptic properties, Oxcarbazepine has mood-stabilizing effects, making it beneficial for individuals with mood disorders associated with epilepsy.\nWell-Tolerated: Generally well-tolerated with a favorable side effect profile compared to other antiepileptic medications.\nOnce-Daily Dosing: The 300 mg dosage allows for flexible dosing schedules, making it easier for patients to adhere to their treatment regimen.\nProven Efficacy: Oxcarbazepine is a well-established medication with a strong track record of efficacy and safety in treating epilepsy.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of OXCARBZEN 300 is 300 mg per day, divided into two doses. The dosage may be gradually increased by a healthcare provider based on the patient's response to treatment and the severity of seizures.\nMaintenance Dosage: The usual maintenance dose ranges from 600 mg to 2400 mg per day, divided into two doses, depending on the patient's needs and response to therapy.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Oxcarbazepine at the same time each day to maintain consistent medication levels in the bloodstream.\nMissed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not take a double dose to make up for a missed one.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\n", "price": 130.0, "discountamount": 39.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "life", "food", "brain", "water", "needs", "EMAIL", "tablet", "600 mg", "safety", "therapy", "2400 mg", "quality", "epilepsy", "response", "severity", "patients", "Benefits", "next dose", "OXCARBZEN", "same time", "two doses", "frequency", "individuals", "bloodstream", "information", "double dose", "Key Features", "Introduction", "sterispharma", "sterisonline", "300 mg dosage", "CALL/WHATSAPP", "Administration", "Initial Dosage", "mood disorders", "Seizure Control", "Proven Efficacy", "Oxcarbazepine IP", "regular schedule", "partial seizures", "treatment regimen", "Mood Stabilization", "Maintenance Dosage", "strong track record", "electrical activity", "healthcare provider", "typical starting dose", "usual maintenance dose", "mood-stabilizing effects", "antiepileptic properties", "flexible dosing schedules", "consistent medication levels", "favorable side effect profile", "other antiepileptic medications", "excessive electrical discharges" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1869, "imageuri": "https://productimages.withfloats.com/actual/667d17c36c582d228f458060.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d17c36c582d228f458060.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T10:40:06.29Z", "updatedon": "2025-12-24T06:33:35.296Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/oxcarbzen-300-/1869", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OXCARBZEN 300 ", "category": "NEUROLOGY RANGE", "tags": [ "OXCARBZEN 300mg", "Oxcarbazepine IP (300mg)", "oxcarbazepine 300 mg tablet uses", "oxcarbazepine side effects sexually" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666acb47aebebd0900164cc8", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "OXCARBZEN 150 ", "description": "OXCARBZEN 150 \nOxcarbazepine IP (150mg)\nIntroduction:\n\nOXCARBZEN 150 contains Oxcarbazepine IP (150 mg), an antiepileptic medication used to manage and treat partial seizures in epilepsy. Oxcarbazepine works by stabilizing the electrical activity in the brain, preventing the excessive electrical discharges that cause seizures.\nKey Features and Benefits:\n\nSeizure Control: Oxcarbazepine effectively reduces the frequency and severity of partial seizures, improving the quality of life for individuals with epilepsy.\nMood Stabilization: Besides its antiepileptic properties, Oxcarbazepine has mood-stabilizing effects, making it beneficial for individuals with mood disorders associated with epilepsy.\nWell-Tolerated: Generally well-tolerated with a favorable side effect profile compared to other antiepileptic medications.\nOnce-Daily Dosing: The 150 mg dosage allows for flexible dosing schedules, making it easier for patients to adhere to their treatment regimen.\nProven Efficacy: Oxcarbazepine is a well-established medication with a strong track record of efficacy and safety in treating epilepsy.\nDosage and Administration:\n\nInitial Dosage: The typical starting dose of OXCARBZEN 150 is 300 mg per day, divided into two doses. The dosage may be gradually increased by a healthcare provider based on the patient's response to treatment and the severity of seizures.\nMaintenance Dosage: The usual maintenance dose ranges from 600 mg to 2400 mg per day, divided into two doses, depending on the patient's needs and response to therapy.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Oxcarbazepine at the same time each day to maintain consistent medication levels in the bloodstream.\nMissed Dose: If a dose is missed, take it as soon as you remember. If it is almost time for the next dose, skip the missed dose and continue with the regular schedule. Do not take a double dose to make up for a missed one.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW \nhttps://www.sterisonline.com/product/oxcarbzen-150-133598", "price": 89.0, "discountamount": 26.7, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "life", "EMAIL", "water", "needs", "brain", "600 mg", "300 mg", "tablet", "safety", "quality", "2400 mg", "therapy", "patients", "Benefits", "epilepsy", "severity", "response", "next dose", "OXCARBZEN", "same time", "two doses", "frequency", "individuals", "bloodstream", "information", "double dose", "Key Features", "Daily Dosing", "Introduction", "sterispharma", "sterisonline", "150 mg dosage", "CALL/WHATSAPP", "Administration", "Initial Dosage", "mood disorders", "Seizure Control", "Proven Efficacy", "Oxcarbazepine IP", "regular schedule", "partial seizures", "treatment regimen", "Mood Stabilization", "Maintenance Dosage", "strong track record", "electrical activity", "healthcare provider", "typical starting dose", "usual maintenance dose", "mood-stabilizing effects", "antiepileptic properties", "flexible dosing schedules", "consistent medication levels", "favorable side effect profile", "other antiepileptic medications", "excessive electrical discharges" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1868, "imageuri": "https://productimages.withfloats.com/actual/667d3e71422dd0be26725b50.png", "tileimageuri": "https://productimages.withfloats.com/tile/667d3e71422dd0be26725b50.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T10:34:47.944Z", "updatedon": "2024-06-27T10:26:51.75Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/oxcarbzen-150-/1868", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "OXCARBZEN 150 ", "category": "NEUROLOGY RANGE", "tags": [ "OXCARBZEN 150", "Oxcarbazepine IP (150mg)", "", "oxcarbazepine uses", "oxcarbazepine 300 mg tablet uses", "oxcarbazepine 150 mg side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "666a9bf44722330554e90097", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "LAMOTROZEN 25 ", "description": "LAMOTROZEN 25 \nLamotrigine (25mg)\nIntroduction:\n\nLAMOTROZEN 25 contains Lamotrigine (25 mg), a versatile antiepileptic medication used to treat partial-onset seizures, generalized seizures of Lennox-Gastaut syndrome, and primary generalized tonic-clonic seizures. Additionally, it is prescribed for the maintenance treatment of bipolar disorder to prevent mood episodes.\nKey Features and Benefits:\n\nSeizure Control: Lamotrigine is effective in reducing the frequency and severity of various types of seizures, including partial-onset seizures and generalized seizures, providing better control over epileptic conditions.\nBipolar Disorder Management: Lamotrigine helps prevent mood episodes in individuals with bipolar disorder, stabilizing mood and reducing the risk of extreme mood swings.\nNeurostabilization: It works by inhibiting voltage-sensitive sodium channels, which stabilizes neuronal membranes and prevents excessive neuronal firing, thereby reducing seizure activity and mood instability.\nConvenient Dosage: The 25 mg strength allows for flexible dosing schedules and adjustments as needed by healthcare providers to achieve optimal therapeutic effects.\nDosage and Administration:\n\nInitial Dosage for Epilepsy: The typical starting dose of LAMOTROZEN 25 (Lamotrigine 25 mg) is usually initiated at a low dose and gradually increased. The starting dose may vary depending on whether Lamotrigine is used alone or in combination with other antiepileptic drugs.\nInitial Dosage for Bipolar Disorder: For bipolar disorder, the initial dose is typically lower and gradually increased according to a titration schedule determined by a healthcare provider.\nMaintenance Dosage: The maintenance dose for epilepsy generally ranges from 100 mg to 500 mg per day, divided into two doses. For bipolar disorder, the maintenance dose typically ranges from 100 mg to 400 mg per day.\nAdministration: The tablet should be taken orally with water, with or without food. It is important to take Lamotrigine at the same times each day to maintain consistent medication levels in the bloodstream.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \n Order NOW\nhttps://www.sterisonline.com/product/lamotrozen-50-134352\n", "price": 85.0, "discountamount": 25.5, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "day", "food", "risk", "EMAIL", "water", "500 mg", "400 mg", "100 mg", "tablet", "Benefits", "low dose", "severity", "Epilepsy", "two doses", "frequency", "LAMOTROZEN", "same times", "adjustments", "combination", "individuals", "bloodstream", "information", "sterispharma", "Introduction", "sterisonline", "Key Features", "initial dose", "various types", "mood episodes", "CALL/WHATSAPP", "Initial Dosage", "25 mg strength", "Administration", "Seizure Control", "seizure activity", "maintenance dose", "mood instability", "Convenient Dosage", "Lamotrigine 25 mg", "Maintenance Dosage", "titration schedule", "Neurostabilization", "neuronal membranes", "extreme mood swings", "healthcare providers", "epileptic conditions", "generalized seizures", "maintenance treatment", "typical starting dose", "partial-onset seizures", "Lennox-Gastaut syndrome", "excessive neuronal firing", "flexible dosing schedules", "other antiepileptic drugs", "Bipolar Disorder Management", "optimal therapeutic effects", "consistent medication levels", "voltage-sensitive sodium channels", "versatile antiepileptic medication", "primary generalized tonic-clonic seizures" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1844, "imageuri": "https://productimages.withfloats.com/actual/666a9bf70b4fc76a99a1fbd0.jpeg", "tileimageuri": "https://productimages.withfloats.com/tile/666a9bf70b4fc76a99a1fbd0.jpeg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-13T07:12:52.134Z", "updatedon": "2024-06-26T10:49:06.365Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/lamotrozen-25-/1844", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "LAMOTROZEN 25 ", "category": "NEUROLOGYRANGE", "tags": [ "Lamotrigine (25mg)", "", "lamotrigine side effects", "lamotrigine side effects weight gain", "lamictal weight gain reviews", "lamotrigine uses" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false }, { "_id": "6661a57d8da3a81d5c6a17dd", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Mycophenolate mofetil 500mg", "description": "MYCOPLASM M 500\nMycophenolate mofetil (500mg)\nMycoplasm M 500 is a medication containing Mycophenolate Mofetil in a 500mg dose. Mycophenolate Mofetil is an immunosuppressive drug used to prevent rejection in organ transplantation, particularly kidney, heart, and liver transplants. It works by inhibiting the proliferation of T and B lymphocytes, which are involved in the immune response that leads to rejection.\n\nThis medication is typically prescribed in combination with other immunosuppressants as part of a comprehensive transplant treatment regimen. It is important to take Mycoplasm M 500 exactly as prescribed by your healthcare provider to ensure optimal therapeutic outcomes and to minimize the risk of rejection or other complications.\n\nCommon side effects of Mycophenolate Mofetil may include gastrointestinal disturbances such as nausea, vomiting, diarrhea, and abdominal pain. It can also increase the risk of infections due to its immunosuppressive effects. Patients should be monitored regularly by their healthcare provider while taking this medication to assess for any potential adverse effects and to adjust the dosage as needed.\n\nMycoplasm M 500 should not be used in pregnant women or those planning to become pregnant without consulting a healthcare professional, as it can cause harm to the developing fetus. Additionally, it may interact with other medications, so it is important to inform your doctor about all the medications you are currently taking before starting Mycoplasm M 500 therapy.For further information:\nEmail: info@sterispharma.com / contact@sterispharma.com\nCall/WhatsApp: 7877551268, 7849827488\nORDER Now: \n\n\n\n\nMycophenolate mofetil 500 mg stands as a cornerstone in modern immunosuppressive therapy, primarily designed to prevent organ transplant rejection in kidney, heart, and liver recipients. As a prodrug, it rapidly converts to its active form, mycophenolic acid (MPA), which selectively targets the proliferation of T and B lymphocytes—key players in immune responses that can attack transplanted organs. This medication, available in convenient 500 mg tablets, offers reliable protection against acute rejection episodes, making it an essential component in post-transplant regimens worldwide.​\n\nProduct Uses\nMycophenolate mofetil 500 mg finds its primary application in solid organ transplantation, where it helps maintain long-term graft survival. For kidney transplant patients, it is typically administered alongside corticosteroids and calcineurin inhibitors like cyclosporine or tacrolimus to suppress the immune system's overreaction to the new organ. In heart and liver transplants, it plays a similar role, reducing the incidence of rejection by inhibiting antibody production and cell-mediated immunity.​\n\nBeyond transplants, healthcare providers increasingly use mycophenolate mofetil 500 mg for various autoimmune conditions. It effectively manages lupus nephritis by curbing inflammation in the kidneys, showing superior efficacy over traditional therapies in preserving renal function. Rheumatoid arthritis patients benefit from its ability to dampen joint inflammation, while those with dermatomyositis or scleroderma experience reduced skin and muscle involvement. Off-label, it treats inflammatory bowel diseases like Crohn's disease and even certain skin disorders such as pemphigus vulgaris, where immune-mediated blistering threatens quality of life.​\n\nKey Benefits\nThe therapeutic advantages of mycophenolate mofetil 500 mg extend far beyond basic immunosuppression, offering patients enhanced outcomes and improved daily living.\n\nSuperior Graft Protection: Clinical data highlight reduced acute rejection rates by up to 50% when combined with standard regimens, leading to better long-term organ function and survival.​\n\nSelective Lymphocyte Targeting: By depleting guanosine nucleotides in T and B cells via inosine monophosphate dehydrogenase (IMPDH) inhibition, it spares other cell types, minimizing broad toxicity seen with older immunosuppressants.​\n\nAnti-Inflammatory Effects: MPA inhibits adhesion molecule glycosylation, preventing lymphocyte recruitment to inflamed sites, which alleviates symptoms in autoimmune flares.​\n\nOral Convenience: The 500 mg formulation allows flexible dosing—typically 1 gram twice daily—without the need for injections, improving patient adherence.​\n\nVersatility Across Conditions: Proven efficacy in lupus, vasculitis, and myositis expands its utility, often allowing steroid dose reduction and fewer relapses.​\n\nCardiovascular and Anticancer Potential: Emerging evidence suggests it delays graft atherosclerosis by reducing lipid oxidation and may hinder tumor progression in certain malignancies due to its impact on nucleotide synthesis.​\n\nThese benefits translate to fewer hospital readmissions, better quality of life, and cost savings in long-term care for transplant and autoimmune patients.​\n\nSide Effects\nWhile mycophenolate mofetil 500 mg provides robust immunosuppression, it carries risks typical of this drug class, necessitating vigilant monitoring.\n\nCommon side effects affect the gastrointestinal tract most prominently, with nausea, vomiting, diarrhea, and abdominal pain occurring in over 30% of users. These often improve with dose adjustments or enteric-coated alternatives, but hydration and antiemetics help manage them effectively.​\n\nHematologic issues like leukopenia, anemia, and thrombocytopenia arise due to bone marrow suppression, requiring regular complete blood counts—weekly initially, then monthly. Infections pose a significant threat, as suppressed immunity increases susceptibility to viral (e.g., CMV), bacterial, and fungal pathogens; prophylactic antivirals are standard.​\n\nLess frequent but notable effects include hypertension, tremor, insomnia, and elevated liver enzymes. Women face heightened risks of congenital malformations if used during pregnancy, mandating effective contraception and pregnancy testing. Rare severe reactions encompass progressive multifocal leukoencephalopathy (PML) from JC virus reactivation and hypersensitivity syndromes.​\n\nDosage and Administration Notes\nStandard dosing for renal transplants involves 1 gram (two 500 mg tablets) twice daily, starting within 72 hours post-surgery, with adjustments for renal impairment. Hepatic transplant patients may require higher initial doses due to metabolism differences. Always take on an empty stomach with water to optimize absorption, avoiding antacids that bind MPA.​\n\nPrecautions and Interactions\nPatients must avoid live vaccines, report fevers promptly, and undergo TB screening pre-treatment. Drug interactions with azathioprine, cholestyramine, or rifampin can alter levels, so pharmacists review regimens closely. Regular monitoring of MPA blood levels ensures therapeutic efficacy without toxicity.​\n\nConclusion\nMycophenolate mofetil 500 mg emerges as a transformative immunosuppressive agent, safeguarding transplanted organs and taming autoimmune storms with its precise mechanism of lymphocyte suppression and anti-inflammatory prowess. By delivering key benefits like reduced rejection, versatile applications, and manageable administration, it empowers patients to reclaim normalcy post-transplant or amid chronic illness. Despite potential side effects, proactive monitoring and personalized dosing mitigate risks, underscoring its value in contemporary medicine. For those navigating transplant recovery or autoimmune challenges, this medication offers hope and stability, backed by decades of clinical validation.\n\n", "price": 775.0, "discountamount": 256.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "part", "Call", "harm", "risk", "Email", "heart", "ORDER", "nausea", "kidney", "dosage", "doctor", "vomiting", "WhatsApp", "Patients", "diarrhea", "rejection", "infections", "500mg dose", "combination", "information", "sterisonline", "proliferation", "B lymphocytes", "abdominal pain", "pregnant women", "immune response", "developing fetus", "other medications", "liver transplants", "other complications", "healthcare provider", "Common side effects", "organ transplantation", "Mycophenolate mofetil", "immunosuppressive drug", "Mycoplasm M 500 therapy", "healthcare professional", "other immunosuppressants", "immunosuppressive effects", "potential adverse effects", "optimal therapeutic outcomes", "gastrointestinal disturbances", "comprehensive transplant treatment regimen" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1472, "imageuri": "https://productimages.withfloats.com/actual/6661a57fdd39d2ccddbc3bb9.jpg", "tileimageuri": "https://productimages.withfloats.com/tile/6661a57fdd39d2ccddbc3bb9.jpg", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-06T12:03:09.216Z", "updatedon": "2025-12-04T07:15:30.023Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/mycophenolate-mofetil-500mg/1472", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "MYCOPLASM M 500", "category": "NEPHROLOGYRANGE", "tags": [ "MYCOPLASM M 500", "Mycophenolate mofetil (500mg)", "Mycophenolate mofetil 500 mg tablet", "Mycophenolate mofetil 500 mg price", "Mycophenolate mofetil 500 mg dosage", "Mycophenolate mofetil uses", "Mycophenolate mofetil side effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.001, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }